November is Pancreatic Cancer Awareness Month

	Tweet

According to the American Cancer Society (ACS), pancreatic cancer is the fourth leading cancer killer in the country, with over 37,000 new cases expected and more than 34,000 deaths by year’s end. In New Jersey alone, an estimated 1,000 deaths are expected this year due to the disease. The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks and treatment and prevention options surrounding pancreatic cancer during this National Pancreatic Cancer Awareness Month. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

The pancreas is a six-inch long, pear-shaped gland (located in the abdomen), which helps make enzymes for food digestion. The lifetime risk for developing pancreatic cancer is one in 76 for both men and women, with African American men having a slightly higher risk. There is only a five-percent, five-year survival rate. According to the ACS, three in ten cases are thought to be caused by smoking. Symptoms include jaundice, fatigue, weight loss and abdominal pain.

CINJ experts available for comment include:

David A. August, M.D., is the chief of the division of surgical oncology at CINJ and professor of surgery at UMDNJ-Robert Wood Johnson Medical School. Dr. August is also the director of CINJ’s Gastrointestinal/Hepatobiliary Oncology Program, which is a multidisciplinary clinical and scientific program that provides comprehensive services to patients with pre-cancerous and cancerous conditions involving the pancreas and other gastrointestinal organs. He can discuss the importance of patients having a comprehensive evaluation under one roof with a close collaboration of multiple specialists including surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists, nurses, pharmacists, social workers and other experts.

Elizabeth Poplin, M.D., is a medical oncologist at CINJ and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School. Dr. Poplin has expertise in the management of pancreatic cancer including standard and novel treatment options, including a new immune therapy trial, which is anticipated to launch in the near future.

Tamir Ben-Menachem, M.D., is a gastroenterologist at CINJ and director of endoscopy and associate professor of medicine at UMDNJ-Robert Wood Johnson Medical School, who has an interest in pancreatic cancer. Dr. Ben-Menachem can discuss his research in advances for early detection of pancreatic cancer, which is thought to be the best way to improve survival from the disease. In addition, he can discuss noninvasive treatment advances, including that of injecting treatment medication directly into the pancreas tumor.

Source: Cancer Institute of New Jersey

RELATED STORIES:
Tests may detect mesothelioma, pancreatic cancer   New combination effective against pancreatic cancer   Dietary fat associated with pancreatic cancer risk   New Treatment for Pancreatic Cancer Allows Life-Saving Surgery   Pancreatic cancer vaccine may improve survival   Researchers Find Gene Therapy that Kills Pancreatic Cancer Cells   UNC team discovers promising target for new pancreatic cancer treatments   Sugary foods linked to pancreatic cancer risk   Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half   Study examines screening for pancreatic cancer in high-risk populations   New drug achieves pancreatic cancer tumor remission and prevents recurrence   Pancreatic Neuroendocrine Cancer   Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others   Alcohol Consumption May Increase Pancreatic Cancer Risk   Islet Cell Tumors (Endocrine Pancreas)   Fizzy drinks increase risk of pancreatic cancer   New molecular therapy candidates for pancreatic cancer   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy   Possible origins of pancreatic cancer revealed   Popular herbal supplement hinders the growth of pancreatic cancer cells   Mayo Clinic Researchers Find Oncogene is Important in Pancreatic Cancer Growth and Spread   Study links sugary soft drinks to pancreatic cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]